EISAI
Eisai is a human health care company that provides products and services to its patients and their families under any healthcare system. Eisai specializes in the integrated pharmaceutical business that operates in business groups it focuses on oncology and neurology, dementia-related diseases and neurodegenerative diseases. The company was founded in 1941 and headquartered in Tokyo, Japan.
EISAI
Industry:
Biotechnology Health Care Health Insurance Pharmaceutical
Founded:
1941-12-06
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.eisai.co.jp
Total Employee:
10001+
Status:
Active
Contact:
81-3-3817-3700
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Apache Global Site Tag
Similar Organizations
Advantage Risk Management
Advantage Risk Management is a mental health care company that provides comprehensive mental health services for companies.
Eisai Europe
Eisai Europe is a human health care company that provides products and services to its patients.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
UNI PHARMA
Unipharma is to provide healthcare products and outstanding services for both pharmaceutical and animal healthcare products.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-01-07 | AkaRx | AkaRx acquired by Eisai | 255 M USD |
| 2007-03-22 | Morphotek | Morphotek acquired by Eisai | 325 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-09 | LIFENET INSURANCE COMPANY | Eisai investment in Post-IPO Equity - LIFENET INSURANCE COMPANY | 300 M JPY |
| 2022-01-27 | Ractigen Therapeutics | Eisai investment in Series A - Ractigen Therapeutics | 30 M USD |
| 2021-09-09 | Neuroglee Therapeutics | Eisai investment in Series A - Neuroglee Therapeutics | 10 M USD |
| 2021-05-04 | ŌURA | Eisai investment in Series C - ŌURA | 100 M USD |
| 2021-04-05 | Allm | Eisai investment in Series A - Allm | 5.6 B JPY |
| 2020-12-03 | Neuroglee Therapeutics | Eisai investment in Pre Seed Round - Neuroglee Therapeutics | 2.3 M USD |
| 2020-11-05 | Unlearn.AI | Eisai investment in Series A - Unlearn.AI | 3 M USD |
| 2020-04-10 | Darmiyan | Eisai investment in Seed Round - Darmiyan | 6.43 M USD |
| 2019-12-12 | Numab | Eisai investment in Series B - Numab | 22 M CHF |
| 2019-05-09 | Allm | Eisai investment in Corporate Round - Allm | N/A |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-27 | Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership |
Official Site Inspections
http://www.eisai.co.jp Semrush global rank: 333.99 K Semrush visits lastest month: 181.62 K
Unable to get host informations!!!
More informations about "Eisai"
エーザイ株式会社｜ヒューマン・ヘルスケアのエーザイ
サステナビリティ「グローバルヘルス分野における日本の企業活動とODAの支援を要請 ー 福岡資麿厚生労働大臣に要望書を手交」掲載 2025年5月15日 2025年4月24日 最新の hhc 活動「 …See details»
Eisai (company) - Wikipedia
Eisai Co., Ltd. (Japanese: エーザイ株式会社, Hepburn: Ēzai Kabushiki-gaisha) is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. See details»
Eisai Inc., a U.S. research-based healthcare company | Eisai Inc.
Eisai Inc. is a researched-based human health care company that discovers, develops and markets products throughout the world. Learn more about Eisai today.See details»
Eisai Australia
Eisai in numbers With operations in Asia, Australia, New Zealand, Europe, the Middle East and the United States, we employ more than 10,000 people …See details»
Meet the inspiring leadership team | Eisai US
Mr. Yasuno has full operating responsibility for the management of Eisai’s operating companies and sites in the United States and Canada, including its …See details»
Eisai Co., Ltd.｜A human health care company
Welcome to the Eisai Official Corporate Website Eisai Co., Ltd. Page.See details»
Eisai Limited Bolsters Canadian Operations with Major ... - Newswire
1 day ago Eisai Limited was established in Canada in 2011 and is one of more than 40 subsidiaries of global, industry-leading, Eisai Co., Ltd. Rooted in Eisai's focus on delivering …See details»
Corporate values and responsibilities | Eisai US
INTEGRITY AT EISAI: ROOTED IN ALL WE DO Integrity is a core value to the Eisai organization. What we mean by integrity is that we strive as a Company …See details»
» Eisai Worldwide
Eisai signs a statement with the World Health Organization (WHO) to supply a primary lymphatic filariasis medicine free of charge. >Zebinix® (eslicarbazepine acetate) launched in Sweden for …See details»
Eisai at a Glance | About Eisai | Eisai Co., Ltd.
Eisai at a Glance A Leading Global Research and Development-Based Pharmaceutical Company Headquartered in Japan Established in 1941, Eisai …See details»
会社概要 | 会社情報 - 会社情報 | エーザイ株式会社
エーザイ株式会社の企業サイトで、会社概要を紹介しています。See details»
Eisai - Crunchbase Company Profile & Funding
Eisai is a human healthcare company that provides products and services to its patients and their families under any healthcare system. They specialize in an integrated pharmaceutical …See details»
Eisai Europe
Eisai in numbers With operations in Asia, Australia, Europe, The Middle East, Latin America, New Zealand and the United States, we employ more than 10,000 people worldwide.See details»
Who we are as a medical solutions company | Eisai US
Eisai was built from an inspired team of innovators relentlessly pursuing way to improve the lives of patients. Learn more about us and our mission today.See details»
About Eisai | Eisai Co., Ltd.
The information provided on the “Investors” website is created for the purpose of providing information on Eisai’s activities for shareholders, investors, and members of the media. As …See details»
組織図 - エーザイ株式会社
グローバルセーフティ本部 メディカル本部 Deep Human Biology Learning(DHBL) Eisai Demand Chain Systems (EDCS) CJ部 APIソリューション事業部 EAファーマ株式会社See details»
Organization chart - Eisai Co., Ltd.
[Eisai Corporate Organization Chart] (as of July 1, 2024) Board of Directors Secretariat Shareholders Meeting Board of DirectorsSee details»
What Matters to Us at EISAI
Eisai believes that diversity is essential to innovation, and we value what every employee brings to our organization.See details»
Eisai Group Worldwide | Corporate Information | Eisai Co., Ltd.
Welcome to the Eisai Official Corporate Website Eisai Group Worldwide PageSee details»
Our human health care mission | Eisai US
Eisai's human health care mission represents our committment to putting patients and their families first. Learn more about our patient-first approach today.See details»